Page results
-
A front page story and patient case study highlight SUMMIT Study early diagnosis outcomes.
-
In a major study involving UCLH a third of people who took a new drug for treating obesity lost more than one-fifth of their total body weight.
-
The world’s first COVID-19 vaccine study researching alternating doses and intervals of approved vaccines is taking place at UCLH.
-
UCLH has recruited the first European participant to a trial looking at treating non-hospitalised Covid-19 patients with the drug remdesivir.
-
This page provides information about the WEB device and how it is used to treat cerebral (brain) aneurysms
-
Our outpatient clinics will remain predominantly virtual throughout the COVID-19 pandemic. Please continue to refer via the NHS e-referral service.
-
All GPs are now welcome to use our national Infectious & Tropical Disease Advice and Guidance function on the e-referral system (NHS e-RS)
-
Around 1 in 250 women may experience consciousness during pregnancy-related surgery under general anaesthesia, according to a national study which sheds light on why this occurs.
-
This page explains what you can expect after you have been referred to the Lymphoedema Service at University College London Hospitals (UCLH) for a video or telephone appointment.
-
UCLH has opened a new vaccine research centre with two clinical trials testing a long-acting antibody combination treatment to protect against Covid-19.
File results
-
FOI/2022/0473 - Miscarriage/ stillbirth data
-
FOI/2022/0475 - Equality, Diversity and Inclusion (EDI) strategy
-
FOI/2022/0476 - Funding allocation for urgent care and emergency services and how much direct funding from CCG
-
FOI/2022/0477 - The Integrated Care Board (ICB) that commissions services from Trust
-
FOI/2022/0478 - Hospital-initiated cancellation of appointments
-
FOI/2022/0481 - Electronic Patient Record system
-
FOI/2022/0482 - Non-emergency patient transport service (NEPTS)
-
FOI/2022/0485 - ACR laboratory device
-
FOI/2022/0486 - Dermatology dept staff details
-
FOI/2022/0487 - ICT spend on telecommunication, mobile handsets/ smartphones